Capital Advisors Ltd’s Akili Inc AKLI Stock Holding History

Capital Advisors Ltd’s Portfolio AKLI Stock Details AKLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-551	Closed	–	–	1533
2023 Q3	$0	Buy	+551	New	+$547	﹤0.01%	1522

Other funds holding AKLI

SCG

Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Advisors Ltd's AKLI Position: Q4 2023 in Review

Capital Advisors Ltd sold out of Akili Inc (AKLI) in Q4 2023, closing a stake of 551 shares.

Capital Advisors Ltd first reported a position in AKLI in Q3 2023 and held it in 1 quarter. The position peaked at $0 in Q3 2023. 34 funds tracked by Wall St. Rank hold AKLI as of Q4 2023.

Capital Advisors Ltd reported no remaining Akili Inc position as of Q4 2023 after selling out during the quarter.
Capital Advisors Ltd sold 551 Akili Inc shares in Q4 2023.
Capital Advisors Ltd first reported a position in Akili Inc in Q3 2023 and held it in 1 quarter.
Capital Advisors Ltd's Akili Inc position peaked at $0 in Q3 2023.
34 funds tracked by Wall St. Rank held Akili Inc as of Q4 2023.

Based on Capital Advisors Ltd's 13F filing for Q4 2023, filed 2 Feb 2024.